Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2016 | 2 |
2017 | 1 |
2023 | 0 |
Search Results
3 results
Results by year
Citations
1
article
found by citation matching
Shared decision-making following disclosure of coronary heart disease genetic risk: results from a randomized clinical trial.
J Investig Med. 2017.
PMID: 27993947
Free PMC article.
Clinical Trial.
Search results
Filters applied: . Clear all
Page 1
Shared decision-making following disclosure of coronary heart disease genetic risk: results from a randomized clinical trial.
Jouni H, Haddad RA, Marroush TS, Brown SA, Kruisselbrink TM, Austin EE, Shameer K, Behnken EM, Chaudhry R, Montori VM, Kullo IJ.
Jouni H, et al.
J Investig Med. 2017 Mar;65(3):681-688. doi: 10.1136/jim-2016-000318. Epub 2016 Dec 19.
J Investig Med. 2017.
PMID: 27993947
Free PMC article.
Clinical Trial.
Whether disclosure of genetic risk for coronary heart disease (CHD) influences shared decision-making (SDM) regarding use of statins to reduce CHD risk is unknown. We randomized 207 patients, age 45-65 y …
Whether disclosure of genetic risk for coronary heart disease (CHD) influences shared de …
Item in Clipboard
Design of a randomized controlled trial of disclosing genomic risk of coronary heart disease: the Myocardial Infarction Genes (MI-GENES) study.
Kullo IJ, Jouni H, Olson JE, Montori VM, Bailey KR.
Kullo IJ, et al.
BMC Med Genomics. 2015 Aug 15;8:51. doi: 10.1186/s12920-015-0122-0.
BMC Med Genomics. 2015.
PMID: 26271327
Free PMC article.
Clinical Trial.
BACKGROUND: Whether disclosure of a genetic risk score (GRS) for a common disease influences relevant clinical outcomes is unknown. ...GRS, followed by shared decision making with a physician regarding statin use. ...
BACKGROUND: Whether disclosure of a genetic risk score (GRS) for a common disease influences relevant clinica …
Item in Clipboard
Incorporating a Genetic Risk Score Into Coronary Heart Disease Risk Estimates: Effect on Low-Density Lipoprotein Cholesterol Levels (the MI-GENES Clinical Trial).
Kullo IJ, Jouni H, Austin EE, Brown SA, Kruisselbrink TM, Isseh IN, Haddad RA, Marroush TS, Shameer K, Olson JE, Broeckel U, Green RC, Schaid DJ, Montori VM, Bailey KR.
Kullo IJ, et al.
Circulation. 2016 Mar 22;133(12):1181-8. doi: 10.1161/CIRCULATIONAHA.115.020109. Epub 2016 Feb 25.
Circulation. 2016.
PMID: 26915630
Free PMC article.
Clinical Trial.
BACKGROUND: Whether knowledge of genetic risk for coronary heart disease (CHD) affects health-related outcomes is unknown. ...Participants in the (+)GRS group were stratified as having high or average/low GRS. Risk was disclosed by a g …
BACKGROUND: Whether knowledge of genetic risk for coronary heart disease (CHD) affects health-related out …
Item in Clipboard
Cite
Cite